The Globe and Mail reports in its Wednesday, Nov. 22, edition that Stifel analyst Daryl Young has assumed coverage on Dentalcorp Holdings with a "buy" ranking. The Globe's David Leeder writes that Mr. Young cut his share target back by $3.50 to $11.50. Analysts on average target the shares at $11.25. Mr. Young believes the stock is trading at an "attractive entry point for [a] recession resistant platform." Mr. Young says in a note: "We are attracted to Dentalcorp's large and highly fragmented market opportunity, strong free cash flow profile as a capital-light services provider and the recession resistant characteristics of dentistry. Furthermore, we believe Dentalcorp holds significant scarcity value as a scaled healthcare service platform, with a recurring patient load and proven repeatable low-risk acquisition model. ... Dentalcorp's valuation has experienced a sharp negative reaction across 2022/2023, precipitated by the dramatic increase in interest rates. In our view, this reflected investor's indiscriminately selling balance sheet risk at the onset, combined with the rising opportunity cost of capital against the somewhat lower returns profile of the dental industry consolidation strategy in recent years."